Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBlue Cross Blue Shield NM Folate Testing Coverage …
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - New MexicoPolicy RPLAB048

    Folate Testing

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - New Mexico Policy RPLAB048 alerts

    Get alerted when Policy RPLAB048 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines Blue Cross Blue Shield - New Mexico reimbursement rules for serum and red blood cell folate testing, and folate receptor autoantibody testing; applies to providers submitting claims to BCBSNM.

    Policy Summary
    PayerBlue Cross Blue Shield - New Mexico
    PolicyFolate Testing
    Policy CodePolicy RPLAB048
    Change TypeRoutine review — no material changes
    Effective DateSep 4, 2026
    Last ReviewSep 4, 2026
    Next Review Date
    Key ActionSubmit accurate documentation and use valid code combinations when filing claims; claims are subject to code edit protocols and review.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2covered clinical indications listed
    RBC not reimbursableRBC folate excluded
    Not reimbursablefolate receptor autoantibody excluded
    3codes shown
    2026-09-04

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    effective date

    Coverage Criteria for Folate Testing

    Coverage criteria for folate testing

    Measurement of serum folate concentration may be reimbursable when one of the following clinical indications is met. Other folate-related tests are restricted as noted.

    ANY of the following

    • Megaloblastic or macrocytic anemia: Measurement of serum folate concentration for individuals with megaloblastic anemia or macrocytic anemia is reimbursable.
    • Bariatric procedures: Measurement of serum folate concentration for individuals who have undergone, or who are scheduled for, bariatric procedures such as Roux-en-Y gastric bypass, sleeve gastrectomy, or biliopancreatic diversion/duodenal switch is reimbursable.
    Exclusions: Measurement of serum folate concentration for all indications not described above is not reimbursable.
    Test-specific exclusions: Measurement of red blood cell (RBC) folate is not reimbursable for any indication; folate receptor autoantibody testing is not reimbursable for any situation.

    Specific Covered Indications

    Megaloblastic or macrocytic anemia

    Serum folate measurement may be reimbursable when the following condition is present.

    Individuals with megaloblastic anemia or macrocytic anemia: Measurement of serum folate concentration is reimbursable for evaluation or management of megaloblastic or macrocytic anemia.

    Pre- or post-bariatric surgery

    Serum folate measurement may be reimbursable when the following condition is present.

    Pre- or post-bariatric surgery: Measurement of serum folate concentration is reimbursable for individuals who have undergone, or who are scheduled for, bariatric procedures such as Roux-en-Y gastric bypass, sleeve gastrectomy, or biliopancreatic diversion/duodenal switch.

    Tests and Indications Not Reimbursable

    Measurement of red blood cell (RBC) folate is explicitly excluded from reimbursement under this policy. The policy states: "For all indications, measurement of red blood cell (RBC) folate is not reimbursable." Providers should not submit claims for RBC folate testing for any indication.

    Testing for folate receptor autoantibodies is not reimbursable under this policy. The document specifies: "For all situations, folate receptor autoantibody testing is not reimbursable." Claims for this test should not be submitted for reimbursement.

    Measurement of serum folate is reimbursable only for the specified clinical indications: megaloblastic or macrocytic anemia, or when the individual has undergone or is scheduled for certain bariatric procedures (e.g., Roux-en-Y gastric bypass, sleeve gastrectomy, biliopancreatic diversion/duodenal switch). The policy states: "For all indications not described above, measurement of serum folate concentration is not reimbursable." Providers should limit serum folate testing to the covered indications when seeking reimbursement.

    Example Procedure Codes

    Example procedure codesCPT
    82746ASSAY OF FOLIC ACID SERUM
    82747ASSAY OF FOLIC ACID RBC
    0399UNEURO CERE FOLATE DEFNCY SRM

    Documentation and Claims Submission

    Documentation Required

    Documentation and claims submission requirements

    Providers are responsible for submitting accurate documentation of services performed and must submit claims using valid code combinations from HIPAA-approved code sets. Claims must be coded according to industry standard coding guidelines (for example: Uniform Billing Editor, AMA CPT Assistant, HCPCS, ICD-10-CM/PCS, NDCs, DRG guidelines, CMS NCCI Policy Manual and CCI edits). Claims are subject to code edit protocols and may be reviewed; providers may be asked to submit additional documentation upon request.

    • Use valid code combinations from HIPAA-approved code sets.
    • Code claims per industry coding guidance (CPT, HCPCS, ICD-10, NCCI/CCI, etc.).
    • Expect code-edit protocols and claim review; provide additional documentation if requested.

    Ordering and Submission Requirements

    Note

    Ordering and plan-specific review

    Providers must review plan documents for product-specific applicability and submit accurate documentation and appropriate coding when ordering folate testing. The policy notes that not all lab management reimbursement requirements apply to each product, so providers should confirm eligible coverage in Plan documents.

    • Review member Plan documents (Certificates, Benefit Booklets, Summary Plan Descriptions) for coverage determinations.
    • Ensure orders and claims reflect accurate coding and documentation consistent with the Plan's reimbursement criteria.

    Policy Scope and Definitions

    Policy scope — Lab management reimbursement criteria
    Scope termLab management reimbursement criteria
    Applies toProviders submitting claims to Blue Cross Blue Shield of New Mexico (BCBSNM)
    Product applicabilityNot all requirements apply to each BCBSNM product; providers should review plan documents for eligible coverage
    Document identifierPolicy RPLAB048, effective 2026-09-04
    Primary subjectReimbursement rules for folate-related laboratory testing (serum folate, RBC folate, folate receptor autoantibody)
    Policy Summary
    PayerBlue Cross Blue Shield - New Mexico
    PolicyFolate Testing
    Policy CodePolicy RPLAB048
    Change TypeRoutine review — no material changes
    Effective DateSep 4, 2026
    Last ReviewSep 4, 2026
    Next Review Date
    Key ActionSubmit accurate documentation and use valid code combinations when filing claims; claims are subject to code edit protocols and review.
    SourceLink
    On This Page
    Coverage Criteria for Folate TestingSpecific Covered IndicationsTests and Indications Not ReimbursableExample Procedure CodesDocumentation and Claims SubmissionOrdering and Submission RequirementsPolicy Scope and Definitions